Hui Chen Wu from Fort Worth, TX, age 69

Real Estate Brokers

Hui Ying Wu, New York Agent

view source

Specialties:

Residential sales
Luxury homes
First time home buyers
Relocation
Property Management
Co-op

Work:

Nest Seekers I N T E R N A T I O N A L
(646)6848699 (Phone)

Client type:

Home Buyers
Home Sellers

Property type:

Condo/Townhome
Multi-family
Co-op

Medicine Doctors

Hui Wu

view source

Specialties:

Internal Medicine

Work:

Sutter Gould Medical GroupSutter Gould Medical Foundation Hospitalists
600 Coffee Rd, Modesto, CA 95355
(209)5241211 (phone), (209)5697778 (fax)

Education:

Medical School
Shanghai Second Med Univ, Shanghai City, Shanghai, China
Graduated: 1999

Languages:

English

Description:

Dr. Wu graduated from the Shanghai Second Med Univ, Shanghai City, Shanghai, China in 1999. She works in Modesto, CA and specializes in Internal Medicine. Dr. Wu is affiliated with Memorial Medical Center.

Hui Wu

view source

Us Patents

Substituted Pyrrolo-Aminopyrimidine Compounds
view source
US Patent:

8580803, Nov 12, 2013
Filed:

Dec 29, 2010
Appl. No.:

12/981138
Inventors:

Yanbin Liu - Acton MA, US
Nivedita Namdev - Westford MA, US
Rocio Palma - North Andover MA, US
Manish Tandon - Framingham MA, US
Jianqiang Wang - Acton MA, US
Hui Wu - Malden MA, US
Assignee:

ArQule, Inc. - Woburn MA
International Classification:

C07D 487/04
A61K 31/519
A61P 35/00
A61P 25/28
A61P 29/00
US Classification:

5142651
Abstract:

The present invention relates to substituted pyrrolo-aminopyrimidine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted pyrrolo-aminopyrimidine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof. The substituted pyrrolo-aminopyrimidine compounds have the following general formula:.

Hdac Inhibitors
view source
US Patent:

20100261710, Oct 14, 2010
Filed:

Aug 21, 2008
Appl. No.:

12/671351
Inventors:

Mark A. Ashwell - Carlisle MA, US
Manish Tandon - Framingham MA, US
Nivedita D. Namdev - Westford MA, US
Jean-Marc Lapierre - Pelham NH, US
Yanbin Liu - Acton MA, US
Hui Wu - Malden MA, US
Assignee:

ARQULE, INC. - Woburn MA
International Classification:

A61K 31/5517
C07D 487/12
C07D 455/06
A61K 31/437
A61K 31/425
C07D 513/04
A61P 35/04
US Classification:

514220, 540561, 546 95, 514294, 514368, 548154
Abstract:

The present invention provides hydroxamic acid compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising the hydroxamic acid compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of the present invention.